D.E. Shaw & Co’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,063
Closed -$24K 5267
2022
Q3
$24K Sell
10,063
-24,920
-71% -$83.9K ﹤0.01% 4787
2022
Q2
$178K Sell
34,983
-16,649
-32% -$85.5K ﹤0.01% 4588
2022
Q1
$339K Sell
51,632
-7,375
-12% -$80.8K ﹤0.01% 4590
2021
Q4
$1.08M Buy
59,007
+2,759
+5% +$91.4K ﹤0.01% 3864
2021
Q3
$2.34M Buy
56,248
+6,064
+12% +$279K ﹤0.01% 2891
2021
Q2
$3.03M Buy
50,184
+3,620
+8% +$223K ﹤0.01% 2515
2021
Q1
$3M Buy
46,564
+6,114
+15% +$420K ﹤0.01% 2232
2020
Q4
$1.7M Buy
+40,450
New +$1.47M ﹤0.01% 2656

Other funds holding GTH

D.E. Shaw & Co's GTH Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Genetron Holdings Limited ADS (GTH) in Q4 2022, closing a stake of 10,063 shares — an estimated $24K sold.

D.E. Shaw & Co first reported a position in GTH in Q4 2020 and held it in 8 quarters. The position peaked at $3.03M in Q2 2021. 22 funds tracked by Wall St. Rank hold GTH as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Genetron Holdings Limited ADS position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 10,063 Genetron Holdings Limited ADS shares in Q4 2022, an estimated $24K.
  • D.E. Shaw & Co first reported a position in Genetron Holdings Limited ADS in Q4 2020 and held it in 8 quarters.
  • D.E. Shaw & Co's Genetron Holdings Limited ADS position peaked at $3.03M in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.